Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates

RAKICI, HALİL; Akdogan, REMZİ; BEDIR, RECEP; Copur, AYŞEGÜL; YILMAZ, Arif

doi:10.1111/1751-2980.12171

Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates

Copy For Citation

RAKICI H., Akdogan R. A., BEDIR R., Copur A., YILMAZ A.

JOURNAL OF DIGESTIVE DISEASES, vol.15, no.9, pp.508-513, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 15 Issue: 9
Publication Date: 2014
Doi Number: 10.1111/1751-2980.12171
Journal Name: JOURNAL OF DIGESTIVE DISEASES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.508-513
Keywords: eradication rate, Helicobacter pylori, moxifloxacin, patients' compliance, resistance, QUADRUPLE THERAPY, 2ND-LINE TREATMENT, RANDOMIZED-TRIAL, METAANALYSIS, PREVALENCE, RESISTANCE, 1ST-LINE, CLARITHROMYCIN, LEVOFLOXACIN, GUIDELINES
Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

ObjectiveTo compare the patients' compliance with and the efficacy of existing treatments for Helicobacter pylori eradication, including moxifloxacin-based triple therapy, sequential treatment and the standard treatment.